eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
3/2024
vol. 49
 
Share:
Share:
abstract:
Original paper

LncRNA DLEU1 contributes to the progression of septic myocardial dysfunction by targeting miR-381-3p

Tian Tian
1
,
Na Zhang
2
,
Guoxin Hu
3
,
Rong Lu
4
,
Jian Liu
5

  1. Department of Geratology, Shengli Oilfield Central Hospital, Dongying, China
  2. Disease Prevention and Control Center of Dongying District, Dongying, China
  3. Department of Emergency, Shengli Oilfield Central Hospital, Dongying, China
  4. Department of Clinical Laboratory, Shengli Oilfield Central Hospital, Dongying, China
  5. Department of Intensive Care Unit, Shengli Oilfield Central Hospital, Dongying, China
Cent Eur J Immunol 2024; 49 (3): 227-237
Online publish date: 2024/11/12
View full text Get citation
 
PlumX metrics:
Introduction:
Cardiac dysfunction is a common complication of sepsis. This study aimed to elucidate the regulatory effect of DLEU1 on sepsis-induced myocardial injury.

Material and methods:
HL-1 cardiomyocytes were treated with lipopolysaccharide (LPS) to mimic sepsis-induced myocardial injury in vitro, and the mouse septic model was established through cecum ligation and perforation (CLP). Cell viability was evaluated using Cell Counting Kit-8 (CCK-8), while apoptosis was assessed via Annexin-V staining. Pro-inflammatory factors including tumor necrosis factor α (TNF-α), interleukin (IL)-1β, IL-6, and oxidative stress indicators were detected by ELISA kits. Cardiac function in mice was determined using cardiac ultrasound, and myocardial indices were detected by ELISA.

Results:
DLEU1 levels were up-regulated gradually in HL-1 cardiomyocytes after LPS treatment in a dose-dependent manner, along with the overactivation of inflammatory responses and oxidative stress. DLEU1 downregulation alleviated LPS-induced cell apoptosis, inflammatory response and oxidative stress. In vivo, DLEU1 knockdown improved the cardiac function of septic mice, and alleviated inflammation and oxidative stress. MiR-381-3p, acting as a competing endogenous RNA (ceRNA) of DLEU1, reversed the effects of DLEU1 in both septic cell and mouse models.

Conclusions:
The results indicate that the DLEU1/miR-381-3p axis is an intrinsic regulator of myocardial injury in sepsis.

keywords:

DLEU1, miR-381-3p, sepsis, myocardial injury, inflammation

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.